SEARCH

SEARCH BY CITATION

Current Awareness

  • 1. Reviews
  • Allard M, Fouquet E, James D, Szlosek-Pinaud M. State of art in 11C labelled radiotracers synthesis. Curr Med Chem 15, 235-277 (2008)
  • Ametamey SM, Honer M, Schubiger PA. Molecular imaging with PET. Chem Rev 108, 1501-1516 (2008)
  • Anderson CJ, Wadas TJ, Wong EH, Weisman GR. Cross-bridged macrocyclic chelators for stable complexation of copper radionuclides for PET imaging. Q J Nucl Med Mol Imaging 52, 185-192 (2008)
  • Bellin MF, Van der Molen AJ. Extracellular gadolinium-based contrast media: An overview. Eur J Radiol 66, 160-167 (2008)
  • Bhatia VK, Senior R. Contrast echocardiography: Evidence for clinical use. J Am Soc Echocardiogr 21, 409-416 (2008)
  • Bouchelouche K, Oehr P. Recent developments in urologic oncology: Positron emission tomography molecular imaging. Curr Opin Oncol 20, 321-326 (2008)
  • Castell F, Cook GJR. Quantitative techniques in 18FDG PET scanning in oncology. Br J Cancer 98, 1597-1601 (2008)
  • Cho ZH, Son YD, Kim HK, Kim KN, Oh SH, Han JY, Hong IK, Kim YB. A fusion PET-MRI system with a high-resolution research tomograph-PET and ultra-high field 7.0 T-MRI for the molecular-genetic imaging of the brain. Proteomics 8, 1302-1323 (2008)
  • Dayton PA, Rychak JJ. Molecular ultrasound imaging using microbubble contrast agents. Front Biosci 12, 5124-5142 (2008)
  • Droste DW. Clinical utility of contrast-enhanced ultrasound in neurosonology. Eur Neurol 59, 2-8 (2008)
  • Emerich DF, Thanos CG. Multifunctional peptide-based nanosystems for improving delivery and molecular imaging. Curr Opin Mol Ther 10, 132-139 (2008)
  • Fujibayashi Y, Suzuki K, Fukumura T, Mori T, Kasamatsu S. Non-standard radionuclide production for PET in Japan. Q J Nucl Med Mol Imaging 52, 140-144 (2008)
  • Herzog H, Tellmann L, Scholten B, Coenen HH, Qaim SM. PET imaging problems with the non-standard positron emitters yttrium-86 and iodine-124. Q J Nucl Med Mol Imaging 52,159-165 (2008)
  • Hesse B, Lindhardt TB, Acampa W, Anagnostopoulos C, Ballinger J, Bax JJ, Edenbrandt L, Flotats A, Germano G, Stopar TG, Franken P, Kelion A, Kjaer A, Le Guludec D, Ljungberg M, Maenhout AF, Marcassa C, Marving J, McKiddie F, Schaefer WM, Stegger L, Underwood R. EANM/ESC guidelines for radionuclide imaging of cardiac function. Eur J Nucl Med Mol Imaging 35, 851-885 (2008)
  • Hoehn M, Himmelreich U, Kruttwig K, Wiedermann D. Molecular and cellular MR imaging: Potentials and challenges for neurological applications. J Magn Reson Imaging 27, 941-954 (2008)
  • Hohn A, Zimmermann K, Schaub E, Hirzel W, Schubiger PA, Schibli R. Production and separation of “non-standard” PET nuclides at a large cyclotron facility: The experiences at the Paul Scherrer Institute in Switzerland. Q J Nucl Med Mol Imaging 52, 145-150 (2008)
  • Honda Y, Fitzgerald PJ. Frontiers in intravascular imaging technologies. Circulation 117, 2024-2037 (2008)
  • Hsu AR, Chen XY. Advances in anatomic, functional, and molecular imaging of angiogenesis. J Nucl Med 49, 511-514 (2008)
  • Klohs J, Wunder A, Licha K. Near-infrared fluorescent probes for imaging vascular pathophysiology. Basic Res Cardiol 103, 144-151 (2008)
  • Kopka K, Schober O, Wagner S. 18F-labelled cardiac PET tracers: Selected probes for the molecular imaging of transporters. Basic Res Cardiol 103, 131-143 (2008)
  • Kraitchman DL, Bulte JWM. Imaging of stem cells using MRI. Basic Res Cardiol 103, 105-113 (2008)
  • Laforest R, Liu X. Image quality with non-standard nuclides in PET. Q J Nucl Med Mol Imaging 52, 151-158 (2008)
  • Laufer EM, Reutelingsperger CPM, Narula J, Hofstra L. Annexin A5: An imaging biomarker of cardiovascular risk. Basic Res Cardiol 103, 95-104 (2008)
  • Lucignani G. Advances in prostate cancer imaging techniques and strategies. Eur J Nucl Med Mol Imaging 35, 1019-1025 (2008)
  • McGuire P, Howes OD, Stone J, Fusar-Poli P. Functional neuroimaging in schizophrenia: Diagnosis and drug discovery. Trends Pharmacol Sci 29, 91-98 (2008)
  • Mendichovszky I, Pedersen M, Frokiaer J, Dissing T, Grenier N, Anderson P, McHugh K, Yang Q, Gordon I. How accurate is dynamic contrast-enhanced MRI in the assessment of renal glomerular filtration rate? A critical appraisal. J Magn Reson Imaging 27, 925-931 (2008)
  • Morcos SK. Extracellular gadolinium contrast agents: Differences in stability. Eur J Radiol 66, 175-179 (2008)
  • Nahrendorf M, Sosnovik DE, Weissleder R. MR-optical imaging of cardiovascular molecular targets. Basic Res Cardiol 103, 87-94 (2008)
  • Nickles RJ, Avila-Rodriguez MA, Nye JA, Houser EN, Selwyn RG, Schueller MJ, Christian BT, Jensen M. Sustainable production of orphan radionuclides at Wisconsin. Q J Nucl Med Mol Imaging 52, 134-139 (2008)
  • Pantaleo MA, Nannini M, Maleddu A, Fanti S, Ambrosini V, Nanni C, Boschi S, Biasco G. Conventional and novel PET tracers for imaging in oncology in the era of molecular therapy. Cancer Treat Rev 34, 103-121 (2008)
  • Penet MF, Glunde K, Jacobs MA, Pathak AP, Bhujwalla ZM. Molecular and functional MRI of the tumor microenvironment. J Nucl Med 49, 687-690 (2008)
  • Qaim SM. Decay data and production yields of some non-standard positron emitters used in PET. Q J Nucl Med Mol Imaging 52, 111-120 (2008)
  • Que EL, Domaille DW, Chang CJ. Metals in neurobiology: Probing their chemistry and biology with molecular imaging. Chem Rev 108, 1517-1549 (2008)
  • Reimer P, Vosshenrich R. Off-label use of contrast agents. Eur Radiol 18, 1096-1101 (2008)
  • Schmitz G. Ultrasonic imaging of molecular targets. Basic Res Cardiol 103, 174-181 (2008)
  • Schneider M. Molecular imaging and ultrasound-assisted drug delivery. J Endourol 22, 795-802 (2008)
  • Schoenberger J, Bauer J, Moosbauer J, Eilles C, Grimm D. Innovative strategies in in vivo apoptosis imaging. Curr Medicinal Chem 15, 187-194 (2008)
  • Sosnovik DE, Nahrendorf M, Weissleder R. Magnetic nanoparticles for MR imaging: Agents, techniques and cardiovascular applications. Basic Res Cardiol 103, 122-130 (2008)
  • Takasawa M, Moustafa RR, Baron JC. Applications of nitroimidazole in vivo hypoxia imaging in ischemic stroke. Stroke 39, 1629-1637 (2008)
  • Tang L. Radionuclide production and yields at Washington University School of Medicine. Q J Nucl Med Mol Imaging 52, 121-133 (2008)
  • Van der Molen AJ, Bellin MF. Extracellular gadolinium-based contrast media: Differences in diagnostic efficacy. Eur J Radiol 66, 168-174 (2008)
  • Waters EA, Wickline SA. Contrast agents for MRI. Basic Res Cardiol 103, 114-121 (2008)
  • Contrast Agents: 3. Chemistry
  • Aime S, Bombieri G, Cavallotti C, Giovenzana GB, Imperio D, Marchini N. An unusual gadolinium ten-coordinated dimeric complex in the series of MRI contrast agents: Na[Gd(H2O)AAZTA] . 3H2O. Inorg Chim Acta 361, 1534-1541 (2008)
  • Alric C, Taleb J, Le Duc G, Mandon C, Billotey C, Le Meur-Herland A, Brochard T, Vocanson F, Janier M, Perriat P, Roux S, Tillement O. Gadolinium chelate coated gold nanoparticles as contrast agents for both X-ray computed tomography and magnetic resonance imaging. J Am Chem Soc 130,5908 (2008)
  • Babic M, Horak D, Trchova M, Jendelova P, Glogarova K, Lesny P, Herynek V, Hajek M, Sykova E. Poly(L-lysine)-modified iron oxide nanoparticles for stem cell labeling. Bioconjug Chem 19, 740-750 (2008)
  • Barcena C, Sra AK, Chaubey GS, Khemtong C, Liu JP, Gao J. Zinc ferrite nanoparticles as MRI contrast agents. Chem Commun 2224-2226 (2008)
  • Bergman L, Rosenholm J, Ost AB, Duchanoy A, Kankaanpaa P, Heino J, Linden M. On the complexity of electrostatic suspension stabilization of functionalized silica nanoparticles for biotargeting and imaging applications. J Nanomater 712514 (2008)
  • Corr SA, Byrne SJ, Tekoriute R, Meledandri CJ, Broughman DF, Lynch M, Kerskens C, O'Dwyer L, Gun'ko YK. Linear assemblies of magnetic nanoparticles as MRI contrast agents. J Am Chem Soc 130, 4214-4215 (2008)
  • Corti M, Lascialfari A, Marinone M, Masotti A, Micotti E, Orsini F, Ortaggi G, Poletti G, Innocenti C, Sangregorio C. Magnetic and relaxometric properties of polyethylenimine-coated superparamagnetic MRI contrast agents. J Magn Magn Mater 320, e316-e319 (2008)
  • Corti M, Lascialfari A, Micotti E, Castellano A, Donativi M, Quarta A, Cozzoli PD, Manna L, Pellegrino T, Sangregorio C. Magnetic properties of novel superparamagnetic MRI contrast agents based on colloidal nanocrystals. J Magn Magn Mater 320, e320-e323 (2008)
  • Ding P, Helquist P, Miller MJ. Design and synthesis of a siderophore conjugate as a potent PSMA inhibitor and potential diagnostic agent for prostate cancer. Bioorg Med Chem 16, 1648-1657 (2008)
  • Dutta S, Park JA, Jung JC, Chang Y, Kim TJ. Gd-complexes of DTPA-bis(amide) conjugates of tranexamic acid and its esters with high relaxivity and stability for magnetic resonance imaging. Dalton Trans 2199-2206 (2008)
  • Kumar S, Aaron J, Sokolov K. Directional conjugation of antibodies to nanoparticles for synthesis of multiplexed optical contrast agents with both delivery and targeting moieties. Nat Protoc 3, 314-320 (2008)
  • Law WC, Yong KT, Roy I, Xu G, Ding H, Bergey EJ, Zeng H, Prasad PN. Optically and magnetically doped organically modified silica nanoparticles as efficient magnetically guided biomarkers for two-photon imaging of live cancer cells. J Phys Chem C 112, 7972-7977 (2008)
  • Leevy WM, Lambert TN, Johnson JR, Morris J, Smith BD. Quantum dot probes for bacteria distinguish Escherichia coli mutants and permit in vivo imaging. Chem Commun 2331-2333 (2008)
  • Li IF, Su CH, Sheu HS, Chiu HC, Lo YW, Lin WT, Chen JH, Yeh CS. Gd2O(CO3)2. H2O particles and the corresponding Gd2O3: Synthesis and applications of magnetic resonance contrast agents and template particles for hollow spheres and hybrid composites. Adv Funct Mater 18, 766-776 (2008)
  • Liong M, Lu J, Kovochich M, Xia T, Ruehm SG, Nel AE, Tamanoi F, Zink JI. Multifunctional inorganic nanoparticles for imaging, targeting, and drug delivery. ACS Nano 2, 889-896 (2008)
  • Norek M, Kampert E, Zeitler U, Peters JA. Tuning of the size of DY2O3 nanoparticles for optimal performance as an MRI contrast agent. J Am Chem Soc 130, 5335-5340 (2008)
  • Overoye-Chan K, Koerner S, Looby RJ, Kolodziej AF, Zech SG, Deng Q, Chasse JM, McMurry TJ, Caravan P. EP-2104R: A fibrin-specific gadolinium-based MRI contrast agent for detection of thrombus. J Am Chem Soc 130, 6025-6039 (2008)
  • Shu CY, Ma XY, Zhang JF, Corwin FD, Sim JH, Zhang EY, Dorn HC, Gibson HW, Fatouros PP, Wang CR, Fang XH. Conjugation of a water-soluble gadolinium endohedral fulleride with an antibody as a magnetic resonance imaging contrast agent. Bioconjug Chem 19, 651-655 (2008)
  • Song Y, Kohlmeir EK, Meade TJ. Synthesis of multimeric MR contrast agents for cellular imaging. J Am Chem Soc 130, 6662-6663 (2008)
  • Sontum PC. Physicochemical characteristics of Sonazoid™, a new contrast agent for ultrasound imaging. Ultrasound Med Biol 34, 824-833 (2008)
  • Terreno E, Sanino A, Carrera C, Castelli DD, Glovenzana GB, Lombardi A, Mazzon R, Milone L, Visigalli M, Aime S. Determination of water permeability of paramagnetic liposomes of interest in MRI field. J Inorg Biochem 102, 1112-1119 (2008)
  • Urbanczyk-Pearson LM, Meade TJ. Preparation of magnetic resonance contrast agents activated by β-galactosidase. Nat Protoc 3, 341-350 (2008)
  • Vasalatiy O, Gerard RD, Zhao P, Sun XK, Sherry AD. Labeling of adenovirus particles with PARACEST agents. Bioconjug Chem 19, 598-606 (2008)
  • Xing GM, Yuan H, He R, Gao XY, Jing L, Zhao F, Chai ZF, Zhao YL. The strong MRI relaxivity of paramagnetic nanoparticles. J Phys Chem B 112, 6288-6291 (2008)
  • 4. Technique
  • Aerts HJWL, Van Reil NAW, Backes WH. System identification theory in pharmacokinetic modeling of dynamic contrast-enhanced MRI: Influence of contrast injection. Magn Reson Med 59, 1111-1119 (2008)
  • Andreisek G, Froehlich JM, Hodler J, Weishaupt D, Beutler V, Pfirrmann CWA, Boesch C, Nanz D. Direct MR arthrography at 1.5 and 3.0 T: Signal dependence on gadolinium and iodine concentrations—phantom study. Radiology 247, 706-716 (2008)
  • Attenberger UI, Michaely HJ, Wintersperger BJ, Sourbron SP, Lodemann KP, Reiser MF, Schoenberg SO. Three-dimensional contrast-enhanced magnetic-resonance angiography of the renal arteries: Interindividual comparison of 0.2 mmol/kg gadobutrol at 1.5 T and 0.1 mmol/kg gadobenate dimeglumine at 3.0 T. Eur Radiol 18, 1260-1268 (2008)
  • Badea CT, Wetzel AW, Mistry N, Pomerantz S, Nave D, Johnson GA. Left ventricle volume measurements in cardiac micro-CT: The impact of radiation dose and contrast agent. Comput Med Imaging Graph 32, 239-250 (2008)
  • Bauditz J, Quinkler M, Beyersdorff D, Wermke W. Improved detection of hepatic metastases of adrenocortical cancer by contrast-enhanced ultrasound. Oncol Rep 19,1135-1139 (2008)
  • Beer AJ, Holzapfel K, Neudorfer J, Piontek G, Settles M, Kroenig H, Peschel C, Schlegel J, Rummeny EJ, Bernhard H. Visualization of antigen-specific human cytotoxic T lymphocytes labeled with superparamagnetic iron-oxide particles. Eur Radiol 18, 1087-1095 (2008)
  • Behrendt FF, Mahnken AH, Keil S, Das M, Hohl C, Bauer D, Seidensticker P, Jost E, Wildberger JE, Gunther RW, Muhlenbruch G. Contrast enhancement in multidetector-row computed tomography (MDCT) of the abdomen: Intraindividual comparison of contrast media containing 300 mg versus 370 mg iodine per ml. Eur Radiol 18, 1199-1205 (2008)
  • Bisdas S, Baghi M, Wagenblast J, Vogl TJ, Thng CH, Koh TS. Gadolinium-enhanced echo-planar T2-weighted MRI of tumors in the extracranial head and neck: Feasibility study and preliminary results using a distributed-parameter tracer kinetic analysis. J Magn Reson Imaging 27, 963-969 (2008)
  • Black KC, Kirkpatrick ND, Troutman TS, Xu LP, Vagner J, Gillies RJ, Barton JK, Utzinger U, Romanowski M. Gold nanorods targeted to δ opioid receptor: Plasmon-resonant contrast and photothermal agents. Mol Imaging 7, 50-57 (2008)
  • Bleicher AG, Kanal E. A serial dilution study of gadolinium-based MR imaging contrast agents. Am J Neuroradiol 29, 668-673 (2008)
  • Bock NA, Paiva FF, Silva AC. Fractionated manganese-enhanced MRI. NMR Biomed 21, 473-478 (2008)
  • Botsoa J, Lysenko V, Geloen A, Marty O, Bluet JM, Guillot G. Application of 3C-SiC quantum dots for living cell imaging. Appl Phys Lett 92, 173902 (2008)
  • Chauvin T, Durand P, Bernier M, Meudal H, Doan BT, Noury F, Badet B, Beloeil JC, Toth E. Detection of enzymatic activity by PARACEST MRI: A general approach to target a large variety of enzymes. Angew Chem Int Ed 47, 4370-4372 (2008)
  • Erogbogbo F, Yong KT, Roy I, Xu GX, Prasad PN, Swihart MT. Biocompatible luminescent silicon quantum dots for imaging of cancer cells. ACS Nano 2, 873-878 (2008)
  • Farrar CT, Dai G, Novikov M, Rosenzweig A, Weissleder R, Rosen BR, Sosnovik DE. Impact of field strength and iron oxide nanoparticle concentration on the linearity and diagnostic accuracy of off-resonance imaging. NMR Biomed 21, 453-463 (2008)
  • Hamdan A, Kelle S, Schnackenburg B, Wellnhofer E, Fleck E, Nagel E. Single-breathhold four-dimensional assessment of left ventricular volumes and function using k-t BLAST after application of extracellular contrast agent at 3 Tesla. J Magn Reson Imaging 27, 1028-1036 (2008)
  • Horton KM, Fishman EK, Gayler B. The use of iohexol as oral contrast for computed tomography of the abdomen and pelvis. J Comput Assist Tomogr 32, 207-209 (2008)
  • Hsu LY, Kellman P, Arai AE. Nonlinear myocardial signal intensity correction improves quantification of contrast-enhanced first-pass MR perfusion in humans. J Magn Reson Imaging 27,793-801 (2008)
  • Kerl JM, Ravenel JG, Nguyen SA, Suranyi P, Thilo C, Costello P, Bautz W, Schoepf UJ. Right heart: Split-bolus injection of diluted contrast medium for visualization at coronary CT angiography. Radiology 247, 356-364 (2008)
  • Kishimoto M, Yamada K, Tsuneda R, Shimizu J, Iwasaki T, Miyake YI. Effect of contrast media formulation on computed tomography angiographic contrast enhancement. Vet Radiol Ultrasound 49, 233-237 (2008)
  • Levman J, Leung T, Causer P, Plewes D, Martel AL. Classification of dynamic contrast-enhanced magnetic resonance breast lesions by support vector machines. IEEE Trans Med Imaging 27, 688-696 (2008)
  • Liu CH, You ZR, Ren JQ, Kim YR, Eikermann-Haerter K, Liu PK. Noninvasive delivery of gene targeting probes to live brains for transcription MRI. FASEB J 22, 1193-1203 (2008)
  • Mailander V, Lorenz MR, Holzapfel V, Musyanovych A, Fuchs K, Wiesneth M, Walther P, Landfester K, Schrezenmeier H. Carboxylated superparamagnetic iron oxide particles label cells intracellularly without transfection agents. Mol Imaging Biol 10, 138-146 (2008)
  • Morgul MH, Raschzok N, Schwartlander R, Vondran FW, Michel R, Stelter L, Pinkernelle J, Jordan A, Teichgraber U, Sauer IM. Tracking of primary human hepatocytes with clinical MRI: Initial results with Tat-peptide modified superparamagnetic iron oxide particles. Int J Artif Organs 31,252-257 (2008)
  • Naganawa S, Satake H, Kawamura M, Fukatsu H, Sone M, Nakashima T. Separate visualization of endolymphatic space, perilymphatic space and bone by a single pulse sequence; 3D-inversion recovery imaging utilizing real reconstruction after intratympanic Gd-DTPA administration at 3 Tesla. Eur Radiol 18, 920-924 (2008)
  • Nural MS, Gokce E, Danaci M, Bayrak IK, Diren HB. Focal liver lesions: Whether a standard dose (0.05 mmol/kg) gadobenate dimeglumine can provide the same diagnostic data as the 0.1 mmol/kg dose. Eur J Radiol 66, 65-74 (2008)
  • Pack NA, DiBella EVR, Wilson BD, McGann CJ. Quantitative myocardial distribution volume from dynamic contrast-enhanced MRI. Magn Reson Imaging 26, 532-542 (2008)
  • Schabel MC, Parker DL. Uncertainty and bias in contrast concentration measurements using spoiled gradient echo pulse sequences. Phys Med Biol 53, 23450-2372 (2008)
  • Shiraishi J, Sugimoto K, Moriyasu F, Kamiyama N, Doi K. Computer-aided diagnosis for the classification of focal liver lesions by use of contrast-enhanced ultrasonography. Med Phys 35, 1734-1746 (2008)
  • Song J, Klibanov AL, Hossack JA, Price RJ. Acoustic attenuation by contrast agent microbubbles in superficial tissue markedly diminishes petechiae bioeffects in deep tissue. Invest Radiol 43, 322-329 (2008)
  • Wang Y, Huang W, Panicek DA, Schwartz LH, Koutcher JA. Feasibility of using limited-population-based arterial input function for pharmacokinetic modeling of osteosarcoma dynamic contrast-enhanced MRI data. Magn Reson Med 59, 1183-1189 (2008)
  • Williams A, Shetty SK, Burstein D, Day CS, McKenzie C. Delayed gadolinium enhanced MRI of cartilage (dGEMRIC) of the first carpometacarpal (1CMC) joint: A feasibility study. Osteoarthritis Cartilage 16, 530-532 (2008)
  • Yamauchi T, Furui S, Suzuki S, Mimura K, Hayashi T, Yamada T, Futami C, Tsukiyama V, Harada M. A simple method to estimate the optimum iodine concentration of contrast material through microcatheters: Hydrodynamic calculation with spreadsheet software. Phys Med Biol 53, 1385-1395 (2008)
  • Yang XY, Liang JC, Heverhagen JT, Jia G, Schmalbrock P, Sammet S, Koch R, Knopp MV. Improving the pharmacokinetic parameter measurement in dynamic contrast-enhanced MRI by use of the arterial input function: Theory and clinical application. Magn Reson Med 59, 1448-1456 (2008)
  • Yong KT, Roy I, Pudavar HE, Bergey EJ, Tramposch KM, Swihart MT, Prasad PN. Multiplex imaging of pancreatic cancer cells by using functionalized quantum rods. Adv Mater 20,1412-1417 (2008)
  • 5. Experimental
  • Al Faraj A, Lacroix G, Alsaid H, Elgrabi D, Stupar V, Robidel F, Gaillard S, Canet-Soulas E, Cremillieux Y. Longitudinal 3He and proton imaging of magnetite biodistribution in a rat model of instilled nanoparticles. Magn Reson Med 59, 1298-1303 (2008)
  • Chan KC, Fu QL, Hui ES, So KF, Wu EX. Evaluation of the retina and optic nerve in a rat model of chronic glaucoma using in vivo manganese-enhanced magnetic resonance imaging. Neuroimage 40, 1166-1174 (2008)
  • Daire JL, Hyacinthe JN, Tatar I, Montet-Abou K, Ivancevic MK, Masterson K, Jorge-Costa M, Morel DR, Vallee JP. In vivo myocardial infarct area at risk assessment in the rat using manganese enhanced magnetic resonance imaging (MEMRI) at 1.5T. Magn Reson Med 59, 1422-1430 (2008)
  • Engberink RDO, La Blezer E, Hoff EI, Van der Pol SMA, Van der Toorn A, Dijkhuizen RM, De Vries HE. MRI of monocyte infiltration in an animal model of neuroinflammation using SPIO-labeled monocytes or free USPIO. J Cereb Blood Flow Metab 28, 841-851 (2008)
  • Gambarota G, Leenders W, Maass C, Wesseling P, Van der Kogel B, Van Tellingen O, Heerschap A. Characterisation of tumour vasculature in mouse brain by USPIO contrast-enhanced MRI. Br J Cancer 98, 1784-1789 (2008)
  • Grillon E, Provent P, Montigon O, Segebarth C, Remy C, Barbier EL. Blood-brain barrier permeability to manganese and to Gd-DOTA in a rat model of transient cerebral ischemia. NMR Biomed 21, 427-436 (2008)
  • Helm PA, Caravan P, French BA, Jacques V, Shen LH, Xu YQ, Beyers RJ, Roy RJ, Kramer CM, Epstein FH. Postinfarction myocardial scarring in mice: Molecular MR imaging with use of a collagen-targeting contrast agent. Radiology 247, 788-796 (2008)
  • Jain TK, Reddy MK, Morales MA, Leslie-Pelecky DL, Labhasetwar V. Biodistribution, clearance, and biocompatibility of iron oxide magnetic nanoparticles in rats. Mol Pharmacol 5,316-327 (2008)
  • Nolte IS, Gungor S, Erber R, Plaxina E, Scharf J, Misselwitz B, Gerigk L, Przybilla H, Groden C, Brockmann MA. In vitro labeling of glioma cells with gadofluorine M enhances T1 visibility without affecting glioma cell growth or motility. Magn Reson Med 59, 1014-1020 (2008)
  • Ramponi S, Rebaudengo C, Cabella C, Grotti A, Vultaggio S, Aime S, Morisetti A, Lorusso V. Contrast-enhanced MRI of murine sponge model for progressive angiogenesis assessed with gadoteridol (ProHance) and gadocoletic acid trisodium salt (B22956/1). J Magn Reson Imaging 27, 872-880 (2008)
  • Van der Zijden JP, Bouts MJRJ, Roeling TAP, Bleys RLAW, Van der Toorn A, Dijkhuizen RM. Manganese-enhanced MRI of brain plasticity in relation to functional recovery after experimental stroke. J Cereb Blood Flow Metab 28, 832-840 (2008)
  • Von zur Muhlen C, Sibson NR, Peter K, Campbell SJ, Wilainam P, Grau GE, Bode C, Choudhury RP, Anthony DC. A contrast agent recognizing activated platelets reveals murine cerebral malaria pathology undetectable by conventional MRI. J Clin Invest 118, 1198-1207 (2008)
  • Walder N, Petter-Puchner AH, Brejnikow M, Redl H, Essig M, Stieljes B. Manganese enhanced magnetic resonance imaging in a contusion model of spinal cord injury in rats: Correlation with motor function. Invest Radiol 43, 277-283 (2008)
  • Wang ZJ, Boddington S, Wendland M, Meier R, Corot C, Daldrup-Link H. MR imaging of ovarian tumors using folate-receptor-targeted contrast agents. Pediatr Radiol 38, 529-537 (2008)
  • Wessig C, Jestaedt L, Sereda MW, Bendszus M, Stoll G. Gadofluorine M-enhanced magnetic resonance nerve imaging: Comparison between acute inflammatory and chronic degenerative demyelination in rats. Exp Neurol 210, 137-143 (2008)
  • Yang J, Khong PL, Wang YX, Chu ACY, Ho SL, Cheung PT, Wu EX. Manganese-enhanced MRI detection of neurodegeneration in neonatal hypoxic-ischemic cerebral injury. Magn Reson Med 59, 1329-1339 (2008)
  • Zurkiya O, Chan AWS, Hu XP. MagA is sufficient for producing magnetic nanoparticles in mammalian cells, making it an MRI reporter. Magn Reson Med 59, 1225-1231 (2008)
  • 6. Applications
  • Dietrich CF, Braden B, Hocke M, Ott M, Ignee A. Improved characterisation of solitary solid pancreatic tumours using contrast enhanced transabdominal ultrasound. J Cancer Res Clin Oncol 134, 635-643 (2008)
  • From AM, Bartholmai BJ, Williams AW, McDonald FS. Iodixanol compared to iohexol for contrast procedures: A case-matched retrospective cohort study. Acta Radiol 49,409-414 (2008)
  • Koh DM, Brown G, Riddell AM, Scurr E, Collins DJ, Allen SD, Chau I, Cunningham D, DeSouza NM, Leach MO, Husband JE. Detection of colorectal hepatic metastases using MnDPDP MR imaging and diffusion-weighted imaging (DWI) alone and in combination. Eur Radiol 18, 903-910 (2008)
  • Koo CW, Shah-Patel LR, Baer JW, Frager DH. Cost-effectiveness and patient tolerance of low-attenuation oral contrast material: Milk versus VoLumen. Am J Roentgenol 190,1307-1313 (2008)
  • Larsson HBW, Hansen AE, Berg HK, Rostrup E, Haraldseth O. Dynamic contrast-enhanced quantitative perfusion measurement of the brain using T1-weighted MRI at 3T. J Magn Reson Imaging 27, 754-762 (2008)
  • Lee Y, Lee JS, Kim CS, Jeong JY, Choi JI, Kim MJ. Area of paradoxical signal drop after the administration of superparamagnetic iron oxide on the T2-weighted image of a patient with lymphangitic metastasis of the liver. Magn Reson Imaging 26, 577-582 (2008)
  • Ross S, Spendlove D, Bolliger S, Christe A, Oesterhelweg L, Grabherr S, Thali MJ, Gygax E. Postmortem whole-body CT angiography: Evaluation of two contrast media solutions. Am J Roentgenol 190, 1380-1389 (2008)
  • Veltman J, Stoutjesdijk M, Mann R, Huisman HJ, Barentsz JO, Blickman JG, Boetes C. Contrast-enhanced magnetic resonance imaging of the breast: The value of pharmacokinetic parameters derived from fast dynamic imaging during initial enhancement in classifying lesions. Eur Radiol 18, 1123-1133 (2008)
  • Molecular Imaging: 7. Carbon
  • Airaksinen AJ, Andersson J, Truong P, Karlsson O, Halldin C. Radiosynthesis of [11C]ximelagatran via palladium catalyzed [11C]cyanation. J Label Compound Radiopharm 51, 1-5 (2008)
  • Bourdier T, Huiban M, Huet A, Sobrio F, Fouquet E, Perrio C, Barre L. Tetra- and monoorganotin reagents in palladium-mediated cross-coupling reactions for the labeling with carbon-11 of PET tracers. Synthesis (Stuttgart) 978-984 (2008)
  • Bramoulle Y, Puech F, Saba W, Valette H, Bottlaender M, George P, Dolle F. Radiosynthesis of (S)-5-methoxymethyl-3-[6-(4,4,4-trifluorobutoxy)benzo[d]isoxazol-3-yl] oxazolidin-2-[11C]one ([11C]SL25.1188), a novel radioligand for imaging monoamine oxidase-B with PET. J Label Compound Radiopharm 51, 153-158 (2008)
  • Chitneni SK, Balzarini J, Celen S, Dyubankova N, Verbruggen AM, Bormans GM. Synthesis and biological evaluation of carbon-11-labeled acyclic and furo[2,3-d] pyrimidine derivatives of bicyclic nucleoside analogues (BCNAs) for structure-brain uptake relationship study of BCNA tracers. J Label Compound Radiopharm 51, 159-166 (2008)
  • Gao M, Wang M, Mock BH, Miller KD, Sledge GW, Hutchins GD, Zheng QH. Synthesis of new carbon-11 labeled cyclofenil derivatives for PET imaging of breast cancer estrogen receptors. Appl Radiat Isot 66, 523-529 (2008)
  • Graff-Guerrero A, Willeit M, Ginovart N, Mamo D, Mizrahi R, Rusjan P, Vitcu I, Seeman P, Wilson AA, Kapur S. Brain region binding of the D2/3 agonist [11C]-(+)-PHNO and the D2/3 antagonist [11C] raclopride in healthy humans. Hum Brain Mapp 29, 400-410 (2008)
  • Jensen SB, Di Santo R, Olsen AK, Pedersen K, Costi R, Cirilli R, Cumming P. Synthesis and cerebral uptake of 1-(1-[11C]methyl-1H-pyrrol-2-yl)-2-phenyl-2-(1-pyrrolidinyl) ethanone, a novel tracer for positron emission tomography studies of monoamine oxidase type A. J Med Chem 51, 1617-1622 (2008)
  • Joshi A, Fessler JA, Koeppe RA. Improving PET receptor binding estimates from Logan plots using principal component analysis. J Cereb Blood Flow Metab 28, 852-865 (2008)
  • Klumpers UMH, Veltman DJ, Boellaard R, Comans EF, Zuketto C, Yaqub M, Mourik JE, Lubberink M, Hoogendijk WJ, Lammertsma AA. Comparison of plasma input and reference tissue models for analysing [11C] flumazenil studies. J Cereb Blood Flow Metab 28, 579-587 (2008)
  • Konno F, Arai T, Zhang MR, Hatori A, Yanamoto K, Ogawa M, Ito G, Odawara C, Yamasaki T, Kato K, Suzuki K. Radiosyntheses of two positron emission tomography probes: [11C] oseltamivir and its active metabolite [11C] Ro 64-0802. Bioorg Med Chem Lett 18, 1260-1263 (2008)
  • Majo VJ, Parsey RV, Prabhakaran J, Mann JJ, Kumar JSD. Synthesis and evaluation of [O-methyl-11C]4-[3-[4-(2-methoxyphenyl)-piperazin-1-yl]propoxyl-4-aza-tricyclo[5.2.1.02,6]dec-8-ene-3,5-dione as a 5-HT1A receptor agonist PET ligand. J Label Compound Radiopharm 51, 132-136 (2008)
  • Milak MS, Severance AJ, Ogden RT, Prabhakaran J, Kumar JSD, Majo VJ, Mann JJ, Parsey RV. Modeling considerations for 11C-CUMI-101, an agonist radiotracer for imaging serotonin 1A receptor in vivo with PET. J Nucl Med 49, 587-596 (2008)
  • Mitsuoka K, Miyoshi S, Kato Y, Murakami Y, Utsumi R, Kubo Y, Noda A, Nakamura Y, Nishimura S, Tsuji A. Cancer detection using a PET tracer, 11C-glycylsarcosine, targeted to H+/peptide transporter. J Nucl Med 49, 615-622 (2008)
  • Reid AE, Ding YS, Eckelman WC, Logan J, Alexoff D, Shea C, Xu Y, Fowler JS. Comparison of the pharmacokinetics of different analogs of 11C-labeled TZTP for imaging muscarinic M2 receptors with PET. Nucl Med Biol 35, 287-298 (2008)
  • Sekimata K, Hatano K, Ogawa M, Abe J, Magata Y, Biggio G, Serra M, Laquintana V, Denora N, Latrofa A, Trapani G, Liso G, Ito K. Radiosynthesis and in vivo evaluation of N-[11C]methylated imidazopyridineacetamides as PET tracers for peripheral benzodiazepine receptors. Nucl Med Biol 35, 327-334 (2008)
  • Sobrio F, Quentin T, Dhilly M, Bourdier T, Tymciu S, Debruyne D, Barre L. Radiosynthesis and ex vivo evaluation of [11C]-SIB-1553A as a PET radiotracer for β4 selective subtype nicotinic acetylcholine receptor. Nucl Med Biol 35, 377-385 (2008)
  • Soloviev D, Fini A, Chierichetti F, Al-Nahhas A, Rubello D. PET imaging with 11C-acetate in prostate cancer: A biochemical, radiochemical and clinical perspective. Eur J Nucl Med Mol Imaging 35, 942-949 (2008)
  • Terakawa Y, Tsuyuguchi N, Iwai Y, Yamanaka K, Higashiyama S, Takami T, Ohata K. Diagnostic accuracy of 11C-methionine PET for differentiation of recurrent brain tumors from radiation necrosis after radiotherapy. J Nucl Med 49, 694-699 (2008)
  • Van Waarde A, Doorduin J, De Jong JR, Dierckx RA, Elsinga PH. Synthesis and preliminary evaluation of (S)-[11C]-exaprolol, a novel β-adrenoceptor ligand for PET. Neurochem Int 52, 729-733 (2008)
  • Wang M, Gao MZ, Miller KD, Sledge GW, Hutchins GD, Zheng QH. Synthesis of new carbon-11-labeled 7-aroyl-aminoindoline-1-sulfonamides as potential PET agents for imaging of tubulin polymerization in cancers. J Label Compound Radiopharm 51, 6-11 (2008)
  • Wang M, Wang JQ, Gao MZ, Zheng QH. Facile synthesis of new carbon-11 labeled conformationally restricted rivastigmine analogues as potential PET agents for imaging AChE and BChE enzymes. Appl Radiat Isot 66, 506-512 (2008)
  • Zoghbi SS, Liow JS, Yasuno F, Hong J, Tuan E, Lazarova N, Gladding RL, Pike VW, Innis RB. 11C-loperamide and its N-desmethyl radiometabolite are avid substrates for brain permeability-glycoprotein efflux. J Nucl Med 49, 649-656 (2008)
  • 8. Fluorine
  • Antenor-Dorsey JAV, Markham J, Moerlein SM, Videen TO, Perlmutter JS. Validation of the reference tissue model for estimation of dopaminergic D2-like receptor binding with [18F]{N-methyl}benperidol in humans. Nucl Med Biol 35, 335-341 (2008)
  • Berndt U, Stanetty C, Wanek T, Kuntner C, Stanek J, Berger M, Bauer M, Henriksen G, Wester HJ, Kvaternik H, Angelberger P, Noe C. Synthesis of a [18F]fluorobenzothiazole as potential amyloid imaging agent. J Label Compound Radiopharm 51, 137-145 (2008)
  • Bucerius J, Schmaljohann J, Bohm I, Palmedo H, Guhlke S, Tiemann K, Schild HH, Biersack HJ, Manka C. Feasibility of 18F-fluoromethylcholine PET/CT for imaging of vessel wall alterations in humans-first results. Eur J Nucl Med Mol Imaging 35, 815-820 (2008)
  • Buck AK, Herrmann K, Zum Bueschenfelde CM, Juweid ME, Bischoff M, Glatting G, Weirich G, Moller P, Wester HJ, Scheidhauer K, Dechow T, Peschel C, Schwaiger M, Reske SN. Imaging bone and soft tissue tumors with the proliferation marker [18F]fluorodeoxythymidine. Clin Cancer Res 14, 2970-2977 (2008)
  • Cheng Z, De Jesus OP, Namavari M, De A, Levi J, Webster JM, Zhang R, Lee B, Syud FA, Gambhir SS. Small-animal PET imaging of human epidermal growth factor receptor type 2 expression with site-specific 18F-labeled protein scaffold molecules. J Nucl Med 49, 804-813 (2008)
  • Fang YHD, Muzic RF. Spillover and partial-volume correction for image-derived input functions for small-animal 18FDG PET studies. J Nucl Med 49, 606-614 (2008)
  • Fischer S, Hiller A, Scheunemann M, Deuther-Conrad W, Hoepping A, Diekers M, Wegner F, Brust P, Steinbach J. Radiosynthesis of novel 18F-labelled derivatives of indiplon as potential GABAA receptor imaging tracers for PET. J Label Compound Radiopharm 51, 123-131 (2008)
  • Frost ML, Blake GM, Park-Holohan SJ, Cook GJR, Curran KM, Marsden PK, Fogelman I. Long-term precision of 18F-fluoride PET skeletal kinetic studies in the assessment of bone metabolism. J Nucl Med 49, 700-707 (2008)
  • Garg S, Lynch AJH, Doke AK, Minton RC, Garg PK. A remote controlled system for the preparation of 7α-[18F]fluoro-17α-methyl 5α-dihydrotestosterone ([18F]FMDHT) using microwave. Appl Radiat Isot 66, 612-618 (2008)
  • Glaser M, Morrison M, Solbakken M, Arukwe J, Karlsen H, Wiggen U, Champion S, Kindberg GM, Cuthbertson A. Radiosynthesis and biodistribution of cyclic RGD peptides conjugated with novel [18F]fluorinated aldehyde-containing prosthetic groups. Bioconjug Chem 19, 951-957 (2008)
  • Harwig CW, Ting R, Adam MJ, Ruth TJ, Perrin DM. Synthesis and characterization of 2,6-difluoro-4-carboxyphenylboronic acid and a biotin derivative thereof as captors of anionic aqueous [18F]-fluoride for the preparation of [18F/19F]-labeled aryltrifluoroborates with high kinetic stability. Tetrahedron Lett 49, 3152-3156 (2008)
  • Hoepping A, Diekers M, Deuther-Conrad W, Scheunemann M, Fischer S, Hiller A, Wegner F, Steinbach J, Brust P. Synthesis of fluorine substituted pyrazolopyrimidines as potential leads for the development of PET-imaging agents for the GABAA receptors. Bioorg Med Chem 16, 1184-1194 (2008)
  • Hoff MN, Yapp DT, Yung AC, Oliver TS, Kozlowski P. In vivo measurement of the hypoxia marker EF5 in Shionogi tumours using 19F magnetic resonance spectroscopy. Int J Radiat Biol 84, 237-242 (2008)
  • Huisman MC, Higuchi T, Reder S, Nekolla SG, Poethko T, Wester HJ, Ziegler SI, Casebier DS, Robinson SP, Schwaiger M. Initial characterization of an 18F-labeled myocardial perfusion tracer. J Nucl Med 49, 630-636 (2008)
  • Jager PL, Chirakal R, Marriott CJ, Brouwers AH, Koopmans KP, Gulenchyn KY. 6-L-18F-fluorodihydroxyphenylalanine PET in neuroendocrine tumors: Basic aspects and emerging clinical applications. J Nucl Med 49, 573-586 (2008)
  • Kramer-Marek G, Kiesewetter DO, Martiniova L, Jagoda E, Lee SB, Capala J. [18F]FBEM-ZHER2:342 -Affibody molecule - A new molecular tracer for in vivo monitoring of HER2 expression by positron emission tomography. Eur J Nucl Med Mol Imaging 35, 1008-1018 (2008)
  • Kwee SA, Thibault GP, Stack RS, Coel MN, Furusato B, Sesterhenn IA. Use of step-section histopathology to evaluate 18F-fluorocholine PET sextant localization of prostate cancer. Mol Imaging 7, 12-20 (2008)
  • Li Z, Lang LX, Ma Y, Kiesewetter DO. [18F]Fluoropropylsulfonyl chloride: A new reagent for radiolabeling primary and secondary amines for PET imaging. J Label Compound Radiopharm 51, 23-27 (2008)
  • Likar Y, Dobrenkov K, Olsz Szewska M, Vider E, Shenker L, Cai S, Pillarsetty N, Hricak H, Ponomarev V. A new acycloguanosine-specific supermutant of herpes simplex virus type 1 thymidine kinase suitable for PET imaging and suicide gene therapy for potential use in patients treated with pyrimidine-based cytotoxic drugs. J Nucl Med 49, 713-720 (2008)
  • Matheoud R, Secco C, Ridone S, Inglese E, Brambilla M. The use of molecular sieves to simulate hot lesions in 18F-fluorodeoxyglucose - Positron emission tomography imaging. Phys Med Biol 53, N137-N148 (2008)
  • Mease RC, Dusich CL, Foss CA, Ravert HT, Dannals RF, Seidel J, Prideaux A, Fox JJ, Sgouros G, Kozikowski AP, Pomper MG. N-[N-[(S)-1,3-dicarboxypropyl]carbamoyl]-4-[18F]fluorobenzyl-L-cysteine, [18F]DCFBC: A new imaging probe for prostate cancer. Clin Cancer Res 14, 3036-3043 (2008)
  • Miyagawa T, Gogiberidze G, Serganova I, Cai S, Balatoni JA, Thaler HT, Ageyeva L, Pillarsetty N, Finn RD, Blasberg RG. Imaging of HSV-tk reporter gene expression: Comparison between [18F]FEAU, [18F]FFEAU, and other imaging probes. J Nucl Med 49, 637-648 (2008)
  • Mullani NA, Herbst RS, O'Neil RG, Gould KL, Barron BJ, Abbruzzese JL. Tumor blood flow measured by PET dynamic imaging of first-pass 18FDG uptake: A comparison with 15O-Labeled water-measured blood flow. J Nucl Med 49, 517-523 (2008)
  • Nishii R, Volgin AY, Mawlawi O, Mukhopadhyay U, Pal A, Bornmann W, Gelovani JG, Alauddin MM. Evaluation of 2′-deoxy-2′-[18F] fluoro-5-methyl-1-β-L-arabinofuranosyluracil ([18F]-L-FMAU) as a PET imaging agent for cellular proliferation: Comparison with [18F]-D-FMAU and [18F]FLT. Eur J Nucl Med Mol Imaging 35, 990-998 (2008)
  • Peng CH, Huang YY, Huang WS, Shiue CY. An automated synthesis of N,N-dimethyl-2-(2-amino-4-[18F]fluorophenylthio)benzylamide (4-[18F]-ADAM) for imaging serotonin transporters. Appl Radiat Isot 66, 625-631 (2008)
  • Prante O, Tietze R, Hocke C, Lober S, Hubner H, Kuwert T, Gmeiner P. Synthesis, radiofluorination, and in vitro evaluation of pyrazolo[1,5-a]pyridine-based dopamine D4 receptor ligands: Discovery of an inverse agonist radioligand for PET. J Med Chem 51, 1800-1810 (2008)
  • Ryu EK, Wu Z, Chen K, Lazarus LH, Marczak ED, Sasaki Y, Ambo A, Salvadori S, Ren C, Zhao H, Balboni G, Chen X. Synthesis of a potent and selective 18F-labeled δ-opioid receptor antagonist derived from the Dmt-Tic pharmacophore for positron emission tomography imaging. J Med Chem 51,1817-1823 (2008)
  • Stadlbauer A, Prante O, Nimsky C, Solomonowitz E, Buchfelder M, Kuwert T, Linke R, Ganslandt O. Metabolic imaging of cerebral gliomas: Spatial correlation of changes in O-(2-18F-fluoroethyl)-L-tyrosine PET and proton magnetic resonance spectroscopic imaging. J Nucl Med 49, 721-729 (2008)
  • Su H, Seimbille Y, Ferl GZ, Bodenstein C, Fueger B, Kim KJ, Hsu YT, Dubinett SM, Phelps ME, Czernin J, Weber WA. Evaluation of [18F]gefitinib as a molecular imaging probe for the assessment of the epidermal growth factor receptor status in malignant tumors. Eur J Nucl Med Mol Imaging 35,1089-1099 (2008)
  • Wilson AA, Garcia A, Parkes J, McCormick P, Stephenson KA, Houle S, Vasdev N. Radiosynthesis and initial evaluation of [18F]-FEPPA for PET imaging of peripheral benzodiazepine receptors. Nucl Med Biol 35, 305-314 (2008)
  • Zeng F, Jarkas N, Stehouwer JS, Voll RJ, Owens MJ, Kilts CD, Nemeroff CB, Goodman MM. Synthesis, in vitro characterization, and radiolabeling of reboxetine analogs as potential PET radioligands for imaging the norepinephrine transporter. Bioorg Med Chem 16, 783-793 (2008)
  • 9. Gallium
  • Jeong JM, Hong MK, Chang YS, Lee YS, Kim YJ, Cheon GJ, Lee DS, Chung JK, Lee MC. Preparation of a promising angiogenesis PET imaging agent: 68Ga-labeled c(RGDyK)-isothiocyanatobenzyl-1,4,7-triazacyclononane-1,4,7-triacetic acid and feasibility studies in mice. J Nucl Med 49, 830-836 (2008)
  • Kayani I, Bomanji JB, Groves A, Conway G, Gacinovic S, Win T, Dickson J, Caplin M, Ell PJ. Functional imaging of neuroendocrine tumors with combined PET/CT using 68Ga-DOTATATE (Dota-DPhe1,Tyr3-octreotate) and 18FDG. Cancer 112, 2447-2455 (2008)
  • Li ZB, Chen K, Chen X. 68Ga-labeled multimeric RGD peptides for microPET imaging of integrin αvβ3 expression. Eur J Nucl Med Mol Imaging 35, 1100-1108 (2008)
  • 11. Indium
  • Muller C, Schibli R, Krenning EP, De Jong M. Pemetrexed improves tumor selectivity of 111In-DTPA-folate in mice with folate receptor-positive ovarian cancer. J Nucl Med 49,623-629 (2008)
  • Stollman TH, Scheer MGW, Leenders WPJ, Verrijp KCN, Soede AC, Oyen WJG, Ruers TJM, Boerman OC. Specific imaging of VEGF-A expression with radiolabeled anti-VEGF monoclonal antibody. Int J Cancer 122, 2310-2314 (2008)
  • 12. Iodine
  • Alagille D, Koren AO, Kudej G, Staley J, Cosgrove K, Seibyl J, Tamagnan GD. 6-[123I]Iodo-2-[[4-(2-methoxyphenyl)piperazin-1-yl]methyl]imidazo[1,2-a]pyridine as potential SPECT agent for imaging dopamine D4 receptor: Synthesis and in vivo evaluation in a nonhuman primate. J Label Compound Radiopharm 51, 202-206 (2008)
  • Farmakis G, Brandau W, Hellwig D, Wollenweber F, Schaefer A, Kirsch CM, Samnick S. PET imaging with p-[124I]iodo-L-phenylalanine as a new tool for diagnosis and postoperative control in patients with glioma. Clin Nucl Med 33, 441-442 (2008)
  • Israel I, Brandau W, Farmakis G, Samnick S. Improved synthesis of no-carrier-added p-[124I]iodo-L-phenylalanine and p-[131I]iodo-L-phenylalanine for nuclear medicine applications in malignant gliomas. Appl Radiat Isot 66, 513-522 (2008)
  • Lee JH, Byeon SR, Lim SJ, Oh SJ, Moon DH, Yoo KH, Chung BY, Kim DJ. Synthesis and evaluation of stilbenylbenzoxazole and stilbenylbenzothiazole derivatives for detecting β-amyloid fibrils. Bioorg Med Chem Lett 18, 1534-1537 (2008)
  • Mattner F, Mardon K, Katsifis A. Pharmacological evaluation of [123I]-CLINDE: A radioiodinated imidazopyridine-3-acetamide for the study of peripheral benzodiazepine binding sites (PBBS). Eur J Nucl Med Mol Imaging 35, 779-789 (2008)
  • Park JH, Kim SW, Yang SD, Hur MG, Chun KS, Yu KH. Synthesis and evaluation of 2-[123I]iodoemodin for a potential breast cancer imaging agent. Bull Korean Chem 29, 595-598 (2008)
  • Pissarek MB, Oros-Peusquens AM, Schramm NU. Challenge by the murine brain: Multi-pinhole SPECT of 123I-labelled pharmaceuticals. J Neurosci Methods 168, 282-292 (2008)
  • Rehfeld NS, Heismann BJ, Kupferschlager J, Aschoff P, Christ G, Pfannenberg AC, Pichler BJ. Single and dual energy attenuation correction in PET/CT in the presence of iodine based contrast agents. Med Phys 35, 1959-1969 (2008)
  • Yu W, Williams L, Malveaux E, Camp VM, Olson JJ, Goodman MM. Synthesis and evaluation of [123I] labeled iodovinyl amino acids syn-, anti-1-amino-3-[2-iodoethenyl]-cyclobutane-1-carboxylic acid, and 1-amino-3-iodomethylene-cyclobutane-1-carboxylic acid as potential SPECT brain tumor imaging agents. Bioorg Med Chem Lett 18, 1264-1268 (2008)
  • 14. Technetium
  • Chen XJ, Yu PR, Zhang LF, Liu B. Synthesis and biological evaluation of 99mTc, Re-monoamine-monoamide conjugated to 2-(4-aminophenyl) benzothiazole as potential probes for β-amyloid plaques in the brain. Bioorg Med Chem Lett 18, 1442-1445 (2008)
  • Chen XJ, Guo YH, Zhang QY, Hao GY, Jia HM, Liu BL. Preparation and biological evaluation of 99mTc-CO-MIBI as myocardial perfusion imaging agent. J Organometal Chem 693,1822-1828 (2008)
  • Edwards D, Jones P, Haramis H, Battle M, Lear R, Barnett DJ, Edwards C, Crawford H, Black A, Godden V. 99mTc-NC100692 - A tracer for imaging vitronectin receptors associated with angiogenesis: A preclinical investigation. Nucl Med Biol 35, 365-375 (2008)
  • Fonge H, Jin LX, Wang HJ, Bormans G, Ni YC, Verbruggen A. Synthesis and preliminary biological evaluation of a 99mTc-labeled hypericin derivative as a necrosis avid imaging agent. J Label Compound Radiopharm 51, 33-40 (2008)
  • Gainkam LOT, Huang L, Caveliers V, Keyaerts M, Hernot S, Vaneycken I, Vanhove C, Revets H, De Baetselier P, Lahoutte T. Comparison of the biodistribution and tumor targeting of two 99mTc-labeled anti-EGFR nanobodies in mice, using pinhole SPECT/micro-CT. J Nucl Med 49, 788-795 (2008)
  • Huang L, Gainkam LOT, Caveliers V, Vanhove C, Keyaerts M, De Baetselier P, Bossuyt A, Revets H, Lahoutte T. SPECT imaging with 99mTc-labeled EGFR-specific nanobody for in vivo monitoring of EGFR expression. Mol Imaging Biol 10, 167-175 (2008)
  • Lane SR, Veerendra B, Rold TL, Sieckman GL, Hoffman TJ, Jurisson SS, Smith CJ. 99mTc(CO)3-DTMA bombesin conjugates having high affinity for the GRP receptor. Nucl Med Biol 35,263-272 (2008)
  • Ludwig C, Chicherio C, Terraneo L, Magistretti P, De Ribaupierre A, Slosman D. Functional imaging studies of cognition using 99mTc-HMPAO SPECT: Empirical validation using the n-back working memory paradigm. Eur J Nucl Med Mol Imaging 35, 695-703 (2008)
  • Luo QY, Wang F, Zhang ZY, Zhang Y, Lu HK, Sun SH, Zhu RS. Preparation and bioevaluation of 99mTc-HYNIC-annexin B1 as a novel radioligand for apoptosis imaging. Apoptosis 13,600-608 (2008)
  • Ponto JA. Special safety considerations in preparation of technetium 99mTc DTPA for cerebrospinal fluid-related imaging procedures. J Am Pharm Assoc 48, 413-416 (2008)
  • Sobal G, Menzel EJ, Sinzinger H. Radiolabeling procedure, quality control and stability of 99mTc-labeled chondroitin sulfate: A new approach of targeting osteoarthritis. Appl Radiat Isot 66, 415-420 (2008)
  • Su ZF, Xu Y. Possible mechanisms of controlling the configuration, stability, and lipophilicity of [99mTcO]N3S and [ReO]N3S chelates. J Label Compound Radiopharm 51, 93-100 (2008)
  • Wang F, Fang W, Zhao M, Wang ZZ, Ji SD, Li Y, Zheng YM. Imaging paclitaxel (chemotherapy)-induced tumor apoptosis with 99mTc C2A, a domain of synaptotagmin I: A preliminary study. Nucl Med Biol 35, 359-364 (2008)
  • Young Kim J, Jun Oh S, Sook Ryu J, Choi SJ, Ha HJ, Hyuk Moon D. Synthesis of 99mTc(CO)3-deoxyuridine derivatives as potential HSV1-tk gene expression imaging agents. Appl Radiat Isot 66, 489-496 (2008)
  • 15. Others
  • Basken NE, Mathias CJ, Lipka AE, Green MA. Species dependence of [64Cu]Cu-bis(thiosemicarbazone) radiopharmaceutical binding to serum albumins. Nucl Med Biol 35, 281-286 (2008)
  • Colabufo NA, Abate C, Contino M, Inglese C, Niso M, Berardi F, Perrone R. PB183, a σ receptor ligand, as a potential PET probe for the imaging of prostate adenocarcinoma. Bioorg Med Chem Lett 18, 1990-1993 (2008)
  • Couillard-Despres S, Finkl R, Winner B, Ploetz S, Wiedermann D, Aigner R, Bogdahn U, Winkler J, Hoehn M, Aigner L. In vivo optical imaging of neurogenesis: Watching new neurons in the intact brain. Mol Imaging 7, 28-34 (2008)
  • Fukukawa KI, Rossin R, Hagooly A, Pressly ED, Hunt JN, Messmore BW, Wooley KL, Welch MJ, Hawker CJ. Synthesis and characterization of core-shell star copolymers for in vivo PET imaging applications. Biomacromolecules 9, 1329-1339 (2008)
  • Haller J, Hyde D, Deliolanis N, De Kleine R, Niedre M, Ntziachristos V. Visualization of pulmonary inflammation using noninvasive fluorescence molecular imaging. J Appl Physiol 104, 795-802 (2008)
  • Huang J, Lee CCI, Sutcliffe JL, Cherry SR, Tarantal AF. Radiolabeling rhesus monkey CD34+ hematopoietic and mesenchymal stem cells with 64Cu-pyruvaldehyde-bis(N4-methylthiosemicarbazone) for microPET imaging. Mol Imaging 7, 1-11 (2008)
  • Inoue Y, Izawa K, Kiryu S, Tojo A, Ohtomo K. Diet and abdominal autofluorescence detected by in vivo fluorescence imaging of living mice. Mol Imaging 7, 21-27 (2008)
  • Kelly KA, Setlur SR, Ross R, Anbazhagan R, Waterman P, Rubin MA, Weissleder R. Detection of early prostate cancer using a hepsin-targeted imaging agent. Cancer Res 68,2286-2291 (2008)
  • Keyaerts M, Verschueren J, Bos TJ, Tchouate-Gainkam LO, Peleman C, Breckpot K, Vanhove C, Caveliers V, Bossuyt A, Lahoutte T. Dynamic bioluminescence imaging for quantitative tumour burden assessment using IV or IP administration of D-luciferin: Effect on intensity, time kinetics and repeatability of photon emission. Eur J Nucl Med Mol Imaging 35, 999-1007 (2008)
  • Knol RJJ, De Bruin K, De Jong J, Van Eck-Smit BLE, Booij J. In vitro and ex vivo storage phosphor imaging of short-living radioisotopes. J Neurosci Methods 168, 341-357 (2008)
  • Law GL, Wong KL, Man CWY, Wong WT, Tsao SW, Lam MHW, Lam PKS. Emissive terbium probe for multiphoton in vitro cell imaging. J Am Chem Soc 130, 3714-3715 (2008)
  • Li C, Greenwood TR, Glunde K. Glucosamine-bound near-infrared fluorescent probes with lysosomal specificity for breast tumor imaging. Neoplasia 10, 389-398 (2008)
  • Li WP, Meyer LA, Capretto DA, Sherman CD, Anderson CJ. Receptor-binding, biodistribution, and metabolism studies of 64Cu-DOTA-cetuximab, a PET-imaging agent for epidermal growth-factor receptor-positive tumors. Cancer Biother Radiopharm 23, 158-171 (2008)
  • Ma LL, Xiang ZD, Sherrill TP, Wang L, Blackwell TS, Williams P, Chong A, Chari R, Yin DP. Bioluminescence imaging visualizes activation of nuclear factor-κB in mouse cardiac transplantation. Transplantation 85, 903-910 (2008)
  • Miao Y, Figueroa SD, Fisher DR, Moore HA, Testa RF, Hoffman TJ, Quinn TP. 203Pb-labeled α-melanocyte-stimulating hormone peptide as an imaging probe for melanoma detection. J Nucl Med 49, 823-829 (2008)
  • Min JJ, Nguyen VH, Kim HJ, Hong YJ, Choy HE. Quantitative bioluminescence imaging of tumor-targeting bacteria in living animals. Nat Protoc 3, 629-636 (2008)
  • Moskaug JO, Carlsen H, Blomhoff R. Noninvasive in vivo imaging of protein kinase A activity. Mol Imaging 7, 35-41 (2008)
  • Rodriguez-Porcel M, Cai WB, Gheysens O, Willmann JK, Chen K, Wang H, Chen IY, He LN, Wu JC, Li ZB, Mohamedali KA, Kim S, Rosenblum MG, Chen X, Gambhir SS. Imaging of VEGF receptor in a rat myocardial infarction model using PET. J Nucl Med 49, 667-673 (2008)
  • Shan L, Hao YB, Wang SP, Korotcov A, Zhang RS, Wang TX, Califano J, Gu XB, Sridhar R, Bhujwalla ZM, Wang PC. Visualizing head and neck tumors in vivo using near-infrared fluorescent transferrin conjugate. Mol Imaging 7, 42-49 (2008)
  • Vavere AL, Lewis JS. Examining the relationship between Cu-ATSM hypoxia selectivity and fatty acid synthase expression in human prostate cancer cell lines. Nucl Med Biol 35,273-279 (2008)
  • Wiseman JM, Ifa DR, Cooks RG, Venter A. Ambient molecular imaging by desorption electrospray ionization mass spectrometry. Nat Protoc 3, 517-524 (2008)